|
Glycosylation changes in cancer: a new class of biomarkers for breast and lung cancer |
Professor Pauline Rudd |
Breast & Lung |
NUI, Dublin |
01/04/2008 |
01/05/2011 |
€239,286 |
|
Children with cancer: Children, parents, and health professionals’ perspectives on children’s participation in shared decision-making. |
Dr Imelda Coyne |
Psycho-Oncology |
Trinity & St James's |
01/04/2008 |
01/12/2010 |
€92,009 |
|
Expressional and Functional Studies of Large ncRNAs in Neuroblastoma Pathogenesis. |
Professor Raymond Stallings |
Brain Tumours |
RCSI & Beaumont |
01/10/2008 |
01/09/2011 |
€239,482 |
|
HPV mRNA and p16 INK4a detection for improved diagnosis and management of cervical neoplasia in smokers. |
Ms Christine White |
Cervical |
Trinity & Coombe Hospital |
01/10/2009 |
30/09/2012 |
€119,990 |
|
Exploring the association between visceral adipose tissue and gastrointestinal malignancy: the role of insulin-like growth factor pathway |
Dr Claire Donohoe |
Gastrointestinal |
Trinity & St James's |
01/10/2009 |
30/09/2012 |
€118,810 |
|
FLT3 signaling in Acute Myeloid Leukaemia |
Ms Joanna Stanicka |
Leukaemia |
NUI, Cork |
01/10/2011 |
30/09/2014 |
€116,310 |
|
The interactions of Nox4 and Bcr-Abl in the survival of leukaemia cells |
Mr William Landry |
Leukaemia |
NUI, Cork |
01/10/2010 |
30/09/2013 |
€119,770 |
|
Targeting the mitochondrial mediated apoptosis pathway to promote cancer cell death |
Professor Mark Lawler |
Leukaemia |
Trinity & St James's |
01/10/2008 |
01/09/2011 |
€207,766 |
|
Tissue and serum microRNA signatures for predicting response to chemoradiotherapy of oesophageal adenocarcinoma |
Dr Stephen Maher |
Oesophageal |
Trinity & St James's |
01/10/2010 |
30/09/2013 |
€208,001 |
|
The role of the chemokine CCL28 (MEC) in oesophageal adenocarcinoma progression; interactions between the tumour and the immune system |
Dr Sarah Picardo |
Oesophageal |
Trinity & St James's |
01/10/2010 |
30/09/2013 |
€117,054 |
|
The Importance of Random Mitochondrial Mutations during Disease Progression in Barrett's Oesophagus |
Dr Naoimh O'Farrell |
Oesophageal |
Trinity & St James's |
01/10/2011 |
30/09/2014 |
€116,400 |
|
An investigation of the thromboxane and prostacyclin synthase pathways in non-small cell lung cancer |
Dr Ken O'Byrne |
Lung |
Trinity & St James's |
01/04/2008 |
01/05/2011 |
€224,086 |
|
The Identification of Biomarkers that Predict Sensitivity/Resistance to PI3K Inhibitors. |
Ms Susan Heavey |
Lung |
Trinity & St James's |
01/10/2011 |
30/09/2014 |
€119,273 |
|
Anti-angiogenic Gene Therapy for Breast Cancer |
Dr Mark Tangney |
Breast |
NUI, Cork |
01/04/2008 |
01/05/2011 |
€195,332 |
|
Understand Cdc7/Dbf4 regulation by microRNAs and its impact in cancer and differentiation |
Dr Laura Barkley |
Breast |
NUI, Galway |
01/10/2008 |
01/09/2011 |
€224,915 |
|
Investigation of the potential of human Mesenchymal Stem Cells (hMSC) as vectors for therapeutic gene delivery to breast tumor tissue |
Dr Roisin Dwyer |
Breast |
NUI, Galway |
01/04/2008 |
01/05/2011 |
€145,019 |
|
Role of xbp1 in breast cancer development and resistance to therapy |
Ms Patricia Cleary |
Breast |
NUI, Galway |
01/10/2011 |
30/09/2014 |
€120,000 |
|
The Role of HER Family Gene Mutations and Other Abnormalities in HER2-amplified Breast Cancer Resistance to HER2-Targeted Therapies. |
Ms Naomi Elster |
Breast |
RCSI & Beaumont |
01/10/2011 |
30/09/2014 |
€120,000 |
|
An analysis of how Q-tRNA influences breast cancer growth and metastasis |
Ms Claire Fergus |
Breast |
Trinity |
01/10/2011 |
30/09/2014 |
€116,950 |
|
The role of ADAMs in mediating resistance to HER-targeted therapies |
Dr Patricia McGowan |
Breast |
UCD & St Vincent's |
01/10/2011 |
30/09/2014 |
€217,936 |
|
To investigate how RACK1 facilitates the activity, substrate specificity and cellular location of PP2A in mammary epithelial cells. |
Ms Maeve Kiely |
Breast |
UL |
01/10/2011 |
30/09/2014 |
€120,000 |
|
Identification and characterisation of guanine nucleotide exchange factors (GEFs) which activate Rab25 during invasive ovarian cancer cell migration |
Dr Conor Horgan |
Ovarian |
NUI, Cork |
01/10/2011 |
30/09/2014 |
€198,474 |
|
microRNA Regulation of the Spindle Assembly Checkpoint (SAC): Implications for Cell Cycle Dysregulation in Ovarian Cancer and Taxol Responsiveness |
Dr Fiona Furlong |
Ovarian |
NUI, Dublin |
01/10/2008 |
01/09/2011 |
€224,826 |
|
The inverse resistance relationship between platinum and taxane chemotherapy in ovarian cancer. |
Dr Britta Stordal |
Ovarian |
Trinity & St James's |
15/11/2010 |
14/10/2013 |
€197,173 |
|
Regulation and Function of Toll-like Receptors in Ovarian Cancer: A Synergistic Model. |
Professor John O'Leary |
Ovarian |
Trinity & St James's |
01/10/2008 |
01/09/2011 |
€150,000 |
|
Hsa-miR-141 and hsa-miR-223 are central to Ovarian Serous Carcinoma Pathogenesis through Regulation of JAG1 and SMARCD1 proteins. |
Dr Richard Flavin |
Ovarian |
Trinity & St James's |
01/04/2008 |
01/05/2011 |
€168,697 |
|
Meaningful methods of identifying psychological distress in patients with advanced cancer |
Dr Pamela Gallagher |
All Cancers |
DCU |
01/10/2008 |
01/09/2010 |
€120,143 |
|
To determine how RACK1 regulates cell migration during tissue morphogenesis and tumorigenesis using 3D culture model systems. |
Dr Patrick Kiely |
All Cancers |
NUI, Cork |
01/10/2009 |
30/09/2012 |
€240,188 |
|
Combined biotherapeutics for the treatment of metastatic cancer |
Dr Michelle Cronin |
All Cancers |
NUI, Cork |
01/10/2011 |
30/09/2014 |
€190,824 |
|
Redox regulation of apoptosis modulating survival pathways in re-current tumours |
Professor Tom Cotter |
All Cancers |
NUI, Cork |
01/04/2008 |
01/05/2011 |
€236,528 |
|
Investigation into the inhibition of angiogenesis by serpins. |
Dr Margaret Worrall |
All Cancers |
NUI, Dublin |
01/10/2008 |
30/09/2011 |
€138,594 |
|
Targeting the Hsp70-IRE1 complex for cancer therapy |
Ms Lisa Vincenz |
All Cancers |
NUI, Galway |
01/10/2010 |
30/09/2013 |
€120,000 |
|
Uncoupling of death receptor-induced nuclear factor kappa B activation from apoptosis |
Dr Eva Szegezdi |
All Cancers |
NUI, Galway |
01/10/2009 |
30/09/2012 |
€195,592 |
|
Mechanisms underlying a psychological intervention for prolonged cancer-related fatigue: a role for symptom perceptions? |
Ms Maria Pertl |
All Cancers |
Trinity & St James's |
01/10/2009 |
30/09/2012 |
€45,000 |
|
Role of the Bcl-2 family protein, Noxa, in sensitivity to platinum-based chemotherapeutics |
Professor Seamus Martin |
All Cancers |
Trinity & St James's |
01/10/2008 |
01/09/2011 |
€223,166 |
|
Specific Targeting of Cancer Stemness: Potential Cancer Therapy? |
Professor John O'Leary |
All Cancers |
Trinity & St James's |
01/04/2008 |
01/05/2011 |
€150,000 |
|
Serological detection and biological validation of antibody-based biomarkers specific to colorectal cancer |
Dr Gregor Kijanka |
Colorectal |
DCU |
01/10/2010 |
30/09/2013 |
€219,985 |
|
Investigating factors associated with compliance in the national population-based colorectal cancer screening programme, with particular emphasis on men. |
Mr Nicholas Clarke |
Colorectal |
NUI, Cork |
01/10/2011 |
30/09/2014 |
€116,095 |
|
Metformin & Colorectal Cancer Outcomes |
Ms Susan Spillane |
Colorectal |
Trinity & St James's |
01/10/2010 |
30/09/2013 |
€85,554 |
|
Examination of the role of thromboxane synthase signalling and its link to tumour angiogenesis in colorectal cancer |
Dr Mary Clare Cathcart |
Colorectal |
Trinity & St James's |
01/10/2011 |
30/09/2014 |
€196,694 |
|
Integrating biomarkers for the stratification of patients into insignificant and significant prostate cancer |
Prof William Watson |
Prostate |
NUI, Dublin |
01/10/2011 |
30/09/2014 |
€750,000 |
|
Cardiac Glycosides and Prostate Cancer Incidence, Outcomes |
Ms Eva Flahavan |
Prostate |
Trinity & St James's |
01/10/2010 |
30/09/2013 |
€86,554 |
|
DNA methylation in prostate cancer: further evaluation of GSTP1, SFRP2 and IGFBP3 as prognostic biomarkers and an unmasking of epigenetically controlled miRNAs. |
Dr Antoinette Perry |
Prostate |
Trinity & St James's |
01/10/2009 |
30/09/2012 |
€212,627 |